Gilmore Neil O'Neill

Companies

• Editas MedicineBoard member Jun 6, 2022 to now¹
• Editas MedicineChief executive officer Jun 6, 2022 to now¹
• Unity Biotechnology, Inc.Board member Dec 14, 2020 to now²
• Aptinyx Inc.Board member Oct 22, 2021 to May 31, 2022³
• Sarepta TherapeuticsSVP & Chief Medical Officer Jun 11, 2018 to Mar 10, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Editas Medicine EDIT243,189 shares⁵$571.5K at $2.35Sep 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Sold 5,124 shares at $3.04 of Editas Medicine⁵
• Jun 3, 2026Sold 15,380 shares at $2.70 of Editas Medicine⁶
• Mar 3, 2026Sold 5,394 shares at $2.02 of Editas Medicine⁷
• Dec 3, 2025Sold 5,603 shares at $2.15 of Editas Medicine⁸
• Sep 3, 2025Sold 5,592 shares at $2.60 of Editas Medicine⁹
• Jun 3, 2025Sold 15,192 shares at $1.72 of Editas Medicine¹⁰
• Mar 4, 2025Sold 16,632 shares at $1.71 of Editas Medicine¹¹
• Dec 3, 2024Sold 1,618 shares at $2.08 of Editas Medicine¹²
• Sep 4, 2024Sold 1,555 shares at $3.42 of Editas Medicine¹³
• Jun 4, 2024Sold 12,191 shares at $5.50 of Editas Medicine¹⁴
• Mar 5, 2024Sold 77,824 shares at $9.42 of Editas Medicine¹⁵
• Mar 2, 2024Granted 72,212 shares of Editas Medicine¹⁵
• Mar 2, 2024Granted 72,213 shares of Editas Medicine¹⁵
• Mar 2, 2024Granted 130,700 shares of Editas Medicine¹⁵
• Jun 5, 2023Sold 6,486 shares at $9.50 of Editas Medicine¹⁶
• Mar 2, 2023Granted 50,000 shares of Editas Medicine¹⁷
• Jun 2, 2022Granted 86,655 shares of Editas Medicine¹⁸